BIOTECHNOLOGY INDUSTRY PARTNERSHIP PROGRAMME (BIPP)

Features of BIPP:

• Support for high risk, accelerated technology development especially in futuristic technologies. Support for very high risk, nationally and socially relevant areas, with no assured market. This would be more of translational research in such cases. It is envisaged that public institutes would be useful partners, so that the basic R&D leads can be translated to product development by the industry. Provides for product evaluation and validation through support for limited and large scale field trial for agriculture products and clinical trials (Phase I, II, III) for health care products. Supporting research project for novel IP generation.

BIPP Categories for Support:

BIPP covers four broad categories (I, II, III & IV) as described below:

• Category I: Areas with major social relevance but uncertain market driven demand
• Category II: High risk, discovery and innovation research with relevance for making India globally competitive
• Category III A: Evaluation & validation of already existing products of high national importance promoting local innovation (Clinical Trials)
• Category III B: Evaluation & validation of already existing products of high national importance promoting local innovation (Agriculture Field Trials)
• Category IV: Shared cost major facilities, critical for enabling innovation

Impact of BIPP (data as on 31st March, 2020):

• Total number of projects supported: 214
  Total fund disbursed: Rs. 523.79 Crore
  Total products/technologies developed: 52
  Facilities developed through BIPP support: 9
  Total IPs generated: 31

Call for proposals:

There are three call for proposals launched in a year:

• 15th February – 31st March
  15th June – 31st July
  15th October – 30th November